Los Angeles Capital Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Los Angeles Capital Management’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-31,071	Closed	-$505K	–	1390
2022 Q1	$505K	Sell	31,071 -6,099	-16%	-$156K	﹤0.01%	1021
2021 Q4	$1.76M	Sell	37,170 -3,446	-8%	-$207K	0.01%	546
2021 Q3	$2.94M	Buy	40,616 +25,556	+170%	+$1.85M	0.01%	438
2021 Q2	$1.26M	Buy	+15,060	New	+$994K	0.01%	757

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Los Angeles Capital Management's NBP Position: Q2 2022 in Review

Los Angeles Capital Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2022, closing a stake of 31,071 shares — an estimated $505K sold.

Los Angeles Capital Management first reported a position in NBP in Q2 2021 and held it in 4 quarters. The position peaked at $2.94M in Q3 2021. 97 funds tracked by Wall St. Rank hold NBP as of Q2 2022.

Los Angeles Capital Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2022 after selling out during the quarter.
Los Angeles Capital Management sold 31,071 NovaBridge Biosciences American Depositary Shares shares in Q2 2022, an estimated $505K.
Los Angeles Capital Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 4 quarters.
Los Angeles Capital Management's NovaBridge Biosciences American Depositary Shares position peaked at $2.94M in Q3 2021.
97 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2022.

Based on Los Angeles Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.